Cancer News and Research

Latest Cancer News and Research

TREM-1 gene disrupts inflammatory process implicated in liver cancer

Researchers at the Georgia Health Sciences University Cancer Center have identified a gene that disrupts the inflammatory process implicated in liver cancer.

23 Aug 2012

Views on Akin and women's health: 'A debate the GOP had hoped to avoid;' Views harkening back to colonial times

Commentators examine the repercussions of the Missouri Senate candidate's comments about rape and abortion.

23 Aug 2012

Life-quality concerns for multiple myeloma survivors

Care of patients with multiple myeloma should not end with the achievement of long-term survival, suggests research indicating many experience poor health-related quality of life in the decade after diagnosis.

22 Aug 2012

Common diabetes treatment may cause bladder cancer

A commonly used diabetes treatment may increase patients’ risk for bladder cancer, show US study findings.

22 Aug 2012

‘Sitting service’ at end of life may improve chances of dying at home

Individuals at the end of their life who use a sitting service to avoid being alone while dying or to give respite to family members who are caring for them, are significantly more likely to die at home than those who do not use such a service, report researchers.

22 Aug 2012

Blood cells returned to stem cell state by Johns Hopkins researchers

Johns Hopkins scientists have developed a reliable method to turn the clock back on blood cells, restoring them to a primitive stem cell state from which they can then develop into any other type of cell in the body.

22 Aug 2012

New medical technology improves image quality and reduces radiation

Particle physicists have developed a new medical technology that combines PET and MRI in one. Benefit: Improved image quality and less radiation.

22 Aug 2012

ASPS launches campaign to educate women about available breast reconstruction options

A new survey released today by the American Society of Plastic Surgeons (ASPS) shows that 89 percent of women want to see what breast reconstruction surgery results would look like before undergoing treatment for breast cancer, prompting the world's largest group of board-certified plastic surgeons to launch a landmark show-and-tell event as part of Breast Reconstruction Awareness (BRA) Day USA, October 17, 2012 in New Orleans.

22 Aug 2012

RNA switches can better equip and regulate viruses for many therapeutic applications

Numerous viruses are used in the service of science today. They serve as gene taxis to transfer therapeutic genes into body cells or as therapeutic viruses targeted to infect and destroy cancer cells. For such applications, the viruses are often equipped with additional genes, such as for immune mediators or for proteins inducing programmed cell death. However, these gene products can harm the body if they are released at the wrong moment or at excessive levels.

22 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

Segasist Technologies launches crowd funding campaign to bring Reconcillio software on cloud

Segasist Technologies, a Canadian software company developing next-generation image contouring platforms for biomedical applications, has launched a crowd funding campaign to bring its software Reconcillio on cloud.

22 Aug 2012

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.

22 Aug 2012

Chemotherapy during pregnancy: an interview with Professor Sibylle Loibl

The incidence is about 1-3% of all breast cancers. The incidence seems to be increasing due to women delaying their childbearing to when they are in their thirties.

22 Aug 2012

Radiation therapy alone no longer the best choice for early follicular lymphoma

A University of Rochester Medical Center study published in the Journal of Clinical Oncology, challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis.

22 Aug 2012

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

Research on a unique vertebrate called the sea lamprey shows that more than a thousand genes are shed during its early development.

22 Aug 2012

Reactions to Rep. Akin's comments: 'Offensive and ignorant;' 'loathsome;' 'bad science'

Opinions are uniformly negative in response to the Senate candidate's comments on rape during a TV interview.

22 Aug 2012

Brand-name drug makers bet coupons will help their products edge out generic competition

If brand-name prescription medicines cost you as little as generic pills, which would you choose? A few drugmakers are betting Americans will stick with the name they know. They've begun offering U.S. patients coupons to reduce copayments on brand-name medicines and compete with new generic versions of the drugs.

22 Aug 2012

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

I consider myself to be a fortunate person. I have a good education, a great job and excellent health insurance. I am a baby boomer who has aged reasonably well and can look forward to a fairly comfortable retirement. I am also fortunate because I was diagnosed with hepatitis C by a proactive and knowledgeable doctor in the late 1990s and had the opportunity to be treated and cured. The odds are that if I had not been diagnosed and treated, I would be on a liver transplant list right now, have liver cancer or even be dead from this disease.

22 Aug 2012

Mof protein plays a key role in epigenetics of stem cells

How do stem cells preserve their ability to become any type of cell in the body? And how do they "decide" to give up that magical state and start specializing? If researchers could answer these questions, our ability to harness stem cells to treat disease could explode. Now, a University of Michigan Medical School team has published a key discovery that could help that goal become reality.

22 Aug 2012

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Oxygen Biotherapeutics, Inc., announced today that recent research conducted by its partner, Aurum Biosciences, Glasgow, Scotland, has shown that Oxycyte, OBI's proprietary perfluorocarbon-based intravenous emulsion, improves imaging of the penumbra following acute ischemic stroke in a rat model.

22 Aug 2012

Cancer News and Research

Latest Cancer News and Research

TREM-1 gene disrupts inflammatory process implicated in liver cancer

Views on Akin and women's health: 'A debate the GOP had hoped to avoid;' Views harkening back to colonial times

Life-quality concerns for multiple myeloma survivors

Common diabetes treatment may cause bladder cancer

‘Sitting service’ at end of life may improve chances of dying at home

Blood cells returned to stem cell state by Johns Hopkins researchers

New medical technology improves image quality and reduces radiation

ASPS launches campaign to educate women about available breast reconstruction options

RNA switches can better equip and regulate viruses for many therapeutic applications

FDA warns consumers about potential health risks of two natural dietary supplements

Segasist Technologies launches crowd funding campaign to bring Reconcillio software on cloud

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

Chemotherapy during pregnancy: an interview with Professor Sibylle Loibl

Radiation therapy alone no longer the best choice for early follicular lymphoma

Study on sea lamprey may indicate how potentially deleterious genes can be controlled

Reactions to Rep. Akin's comments: 'Offensive and ignorant;' 'loathsome;' 'bad science'

Brand-name drug makers bet coupons will help their products edge out generic competition

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

Mof protein plays a key role in epigenetics of stem cells

OBI’s Oxycyte improves imaging of penumbra following acute ischemic stroke

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in